Wegovy 0.5mg weight loss: what happens at this stage of treatment

Step 1: arriving at 0.5mg after your first month

The Wegovy journey starts at 0.25mg, a dose designed entirely to help your body adjust to semaglutide, not to produce major weight loss. After roughly four weeks, your prescriber moves you to 0.5mg. This is the first dose where many people begin to feel a meaningful shift in appetite: food feels less urgent, portion sizes shrink naturally, and the urge to snack between meals quietens. If you've just reached this step and feel impatient, that's understandable. A month in and the scales haven't moved much yet. That frustration is something our prescribers hear regularly, and it's worth knowing it doesn't mean the medicine isn't working. You can read more about what to expect from weight loss on the 0.25mg starting dose if you want to understand what the first four weeks typically look like before this step.

The 0.5mg dose works through semaglutide's action on GLP-1 receptors in the brain and gut. It slows gastric emptying (food leaves your stomach more gradually), reduces hunger signals, and increases the sense of fullness after smaller amounts. The practical result: most people eat less without consciously trying to restrict calories. You can read more about how the broader dose schedule fits together on our Wegovy doses page.

Weight change at this stage varies. Some people lose two or three kilograms in this four-week window; others lose very little. Both are within the range the clinical literature documents. The 0.5mg phase is part of a longer process, not a standalone treatment.

Step 2: what the evidence says about weight loss on Wegovy 0.5mg

The large-scale evidence base for Wegovy focuses on the full titrated dose of 2.4mg, where STEP 1 (published in the New England Journal of Medicine) found an average body-weight reduction of around 15% over 68 weeks in adults with obesity or overweight and a weight-related condition. That headline figure is achieved at maintenance, not at 0.5mg.

At the 0.5mg level, you're in the early titration window. The clinical trials weren't designed to isolate weight loss by dose step, so there's no published figure for exactly how much weight people lose specifically during a 0.5mg month. What the data does show is that meaningful, sustained loss accumulates as doses increase, the trajectory matters more than any single step. If you'd like to see what the picture looks like further along, our page on weight loss at the 2.4mg maintenance dose puts the full-programme results in context.

The key point for this stage: 0.5mg is doing real pharmacological work even if the scales aren't reflecting it dramatically yet. Appetite suppression, changes in food preference, and improved satiety are all happening. Those shifts compound over the weeks that follow.

Step 3: managing side effects at 0.5mg and knowing when to pause

For many people, the move from 0.25mg to 0.5mg is when GI side effects become more noticeable. Nausea is the most common, followed by looser stools, indigestion, and occasionally vomiting. These are usually mild to moderate and tend to settle within the first week or two at the new dose. Eating smaller meals, avoiding very fatty or spicy food, and staying well hydrated helps considerably.

If side effects at 0.5mg are making everyday life difficult, your prescriber can decide to hold the dose there for longer, skipping to 1mg before your body has settled is counterproductive. There's nothing wrong with spending eight weeks at 0.5mg rather than four. Dose increases are always a clinical decision, not an automatic calendar event.

Serious symptoms require prompt attention: severe stomach pain, particularly pain that radiates toward the back, warrants urgent medical review given the known (though uncommon) association between GLP-1 medicines and pancreatitis. The MHRA's Yellow Card scheme lets patients report any suspected side effect directly to the regulator, and using it contributes to the ongoing safety picture for these medicines. For a detailed look at what happens if weight loss stalls specifically at this stage, our page on no weight loss on Wegovy 0.5mg covers the common reasons and what to consider next.

Step 4: moving forward, and what the 0.5mg phase is really preparing you for

The 0.5mg step is a bridge. Its job is to bring your dose up safely while your gut adapts, so that when you reach 1mg (and eventually the higher maintenance steps) the medicine is working in a body that can tolerate it well. People who rush the titration often find side effects force them back down anyway, losing weeks in the process.

Once your prescriber is satisfied that 0.5mg is well tolerated, you'll typically move to 1mg for another four weeks. Our page on weight loss at the 1mg step explains what to expect as appetite suppression deepens further. The full Wegovy treatment journey (titration schedule, eligibility, and the clinical evidence) is covered on our main Wegovy information page.

If you haven't started treatment yet and want to understand the private prescription route, including what a clinical assessment involves and how the process works, you can explore your options through our weight-loss treatments page. A prescriber reviews every consultation personally. That matters more than it might sound.